Caribou Biosciences to Participate in Upcoming Investor Conferences
07 nov. 2022 16h05 HE
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the company’s...